Omer Kucuk, MD

One star
One star
One star
One star
One half star

Rating: 4.9 out of 5 (349 ratings)

Role

Medical Oncology
Specialty

Prostate Cancer Bladder Cancer Kidney (Renal) Cancer Penile Cancer Testicular Cancer
Research Program

Cancer Prevention and Control
Practicing Since

1981

Call 404-778-1900

Background

Omar Kucuk, MD brings to Emory an impressive track record of groundbreaking research in cancer prevention through nutritional components. He has been conducting clinical trials with lycopene and soy isoflavones in combination with standard therapy for prostate cancer since 1996. Nutrition and cancer therapy is Dr. Kucuk's primary research focus.

Carotenoids, isoflavones, zinc, selenium, and folic acid are among the cancer-preventing compounds found in vegetables and fruits, says Dr. Kucuk. Our current investigations focus on the effects of micronutrients and phytochemicals on biomarkers of cell growth, differentiation, inflammation and oxidative stress in a variety of cancers.

Dr. Kucuk conducted the first clinical trials with lycopene and soy isoflavones in prostate cancer and was the first to report the benefits of lycopene and soy isoflavones in the treatment of prostate cancer patients. He reported that lycopene and soy isoflavones have efficacy in patients with hormone-naïve as well as hormone-refractory prostate cancer.

He was the first to report the sensitization of prostate cancer cells to chemotherapy and radiation therapy by soy isoflavones and the first to report that soy isoflavones prevent the adverse effects of radiation in prostate cancer patients.

These studies were done in collaboration with other investigators at Karmanos Cancer Institute and Wayne State University, Detroit, Michigan. Future studies at Emory Winship Cancer Institute will continue to investigate the role of soy isoflavones and other nutritional compounds alone or in combination with chemotherapy and radiation in the treatment of prostate cancer.

Dr. Kucuk is conducting innovative clinical trials to investigate new approaches to prostate and bladder cancer therapy using combinations of chemotherapy, radiation therapy and nutritional agents.

He has also been very active internationally with collaborative research projects and international conferences conducted with scientists in Turkey, Israel, Brazil, Canada, and Norway. He organized the First International Congress on Nutrition and Cancer in Antalya, Turkey in May 2008. He was also the first to report that dietary lycopene intake prevents kidney cancer in Eker rat, ovarian cancer in laying hen and leiomyoma in the Japanese quail in collaboration with veterinary researchers at Firat University, Elazig, Turkey.

Titles & Roles

Professor and Correll Chair in Genitourinary Cancer, Department of Hematology and Medical Oncology

Emory University School of Medicine

Education & Training

Education

Fellowship, Hematology & Oncology, 1981
Northwestern Feinberg School of Medicine
Fellowship, Hematology & Oncology, 1980
St. Francis Hospital - Evanston
Residency, Internal Medicine, 1978
St. Francis Hospital - Evanston
Internship, Internal Medicine, 1976
St. Francis Hospital - Evanston
Medical Education, MD, 1975
Hacettepe University

Board Certifications

Medical Oncology
American Board of Internal Medicine, 1989
Hematology
American Board of Internal Medicine, 1984
Internal Medicine
American Board of Internal Medicine, 1978

Professional Memberships

American Association for Cancer Research
American Society of Clinical Oncology
American Urological Association
Society of Basic Urological Research
Society of Integrative Oncology
Academic Consortium for Integrative Medicine and Health

Research

Publications

Title/Journal	Authors	Publication Date
Novel Skp1 inhibitor has potent preclinical efficacy against castration-resistant prostate cancer. British journal of cancer	X Li, K Mamouni, R Zhao, L Bai, Y Chen, Y Wu, ZR Xie, GA Sautto, D Liu, NJ Bowen, A Danaher, D Li, N Cook, S Grayson, J Zhu, IM Coleman, PS Nelson, Q Bao, J Zhou, AO Osunkoya, O Kucuk, L Gera, D Wu	04/19/2025
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial. Nature cancer	MA Bilen, BT Vo, Y Liu, R Greenwald, AH Davarpanah, D McGuire, R Shiradkar, L Li, A Midya, B Nazha, JT Brown, S Williams, W Session, G Russler, S Caulfield, SS Joshi, VM Narayan, CP Filson, K Ogan, O Kucuk, BC Carthon, L Del Balzo, A Cohen, A Boyanton, N Prokhnevska, MA Cardenas, E Sobierajska, CS Jansen, DH Patil, E Nicaise, AO Osunkoya, HT Kissick, VA Master	03/01/2025
Characteristics, Treatment, and Outcomes of Primary Urethral Cancer: A Multicenter Review Over Two Decades. Clinical genitourinary cancer	BD Hopkins, DC Qian, KM Xu, A McCook-Veal, J Switchenko, LM Hartsell, CB Cimmino, SS Joshi, V Narayan, VA Master, B Nazha, BC Carthon, MA Bilen, O Kucuk, JW Shelton, PR Patel, AB Jani, JS Remick, TY Eng	02/01/2025
Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience. Journal of immunotherapy and precision oncology	TZ Zhuang, S Goyal, KB Case, TA Olsen, S Vemuru, A Yildirim, RV Goswamy, JT Brown, BC Carthon, O Kucuk, MA Bilen, VA Master, B Nazha	02/01/2025
Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer-Updated Report of NRG/RTOG 0712: A Randomized Phase 2 Trial. International journal of radiation oncology, biology, physics	JJ Coen, JP Rodgers, PJ Saylor, CT Lee, CL Wu, W Parker, T Lautenschlaeger, AL Zietman, J Efstathiou, AB Jani, O Kucuk, L Souhami, SL Pugh, HM Sandler, WU Shipley	01/01/2025
Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors. Therapeutic advances in medical oncology	A Yildirim, M Wei, Y Liu, B Nazha, JT Brown, BC Carthon, Y Choi, L Suh, RV Goswamy, GR McClintock, C Hartman, S Caulfield, J Ciuro, JM Goldman, WB Harris, O Kucuk, VA Master, MA Bilen	01/01/2025
The Role of Curcumin in Preventing Naturally Occurring Leiomyoma in the Galline Model. Pharmaceuticals (Basel, Switzerland)	K Sahin, C Orhan, M Tuzcu, N Sahin, IH Ozercan, N Kabil, O Kucuk, B Ozpolat	12/21/2024
PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation. Cancer	DJ Martini, KB Case, D Gratz, K Pellegrini, E Beagle, T Schneider, M Dababneh, B Nazha, JT Brown, SS Joshi, VM Narayan, K Ogan, VA Master, BC Carthon, O Kucuk, LR Harik, MA Bilen	11/01/2024
The diagnostic challenges of differentiating metastatic extramammary Paget disease and prostatic adenocarcinoma: A case report and review of the literature. Urology case reports	G Palmateer, EH Nicaise, J Gandhi, T Goodstein, M Sheng, K Ogan, O Kucuk, M Yushak, MG Sanda, KA Delman, V Master	11/01/2024
Recommendations for Healthy Lifestyle for Cancer Prevention and Healthy Aging. Journal of cancer prevention	O Kucuk, VA Master	09/30/2024
The Interplay between Structural Inequality, Allostatic Load, Inflammation, and Cancer in Black Americans: A Narrative Review. Cancers	AR Esdaille, NK Kuete, VI Anyaeche, E Kalemoglu, O Kucuk	08/30/2024
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial. Research square	MA Bilen, BT Vo, Y Liu, R Greenwald, AH Davarpanah, D McGuire, R Shiradkar, L Li, B Nazha, JT Brown, S Williams, W Session, G Russler, S Caulfield, SS Joshi, VM Narayan, CP Filson, K Ogan, O Kucuk, BC Carthon, L Del Balzo, A Cohen, A Boyanton, N Prokhnevska, MA Cardenas, E Sobierajska, CS Jansen, DH Patil, E Nicaise, AO Osunkoya, H Kissick, VA Master	08/08/2024
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers. Cancer	B Nazha, T Zhuang, S Wu, JT Brown, D Magee, BC Carthon, O Kucuk, C Nabhan, PC Barata, EI Heath, CJ Ryan, RR McKay, VA Master, MA Bilen	12/15/2023
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors. The oncologist	GE Sanda, JM Shabto, S Goyal, Y Liu, DJ Martini, B Nazha, JT Brown, LB Yantorni, G Anne Russler, S Caulfield, SS Joshi, VM Narayan, H Kissick, K Ogan, VA Master, BC Carthon, O Kucuk, MA Bilen	12/11/2023
Is vitamin A an antioxidant? International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition	T Bohn, V Böhm, J Dulińska-Litewka, JF Landrier, D Bánáti, O Kucuk, P Borel, JA Canas, R Rühl	12/01/2023
Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models. British journal of cancer	X Li, Y Chen, L Bai, R Zhao, Y Wu, ZR Xie, JM Wu, NJ Bowen, A Danaher, N Cook, D Li, M Qui, Y Du, H Fu, AO Osunkoya, O Kucuk, D Wu	09/01/2023
Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models. Translational oncology	L Bai, X Li, Y Yang, R Zhao, EZ White, A Danaher, NJ Bowen, CV Hinton, N Cook, D Li, AY Wu, M Qui, Y Du, H Fu, O Kucuk, D Wu	08/01/2023
Lycopene in Prevention of Infertility After Testicular Surgery Regarding Urology. 2022;164:267-272. doi:10.1016/j.urology.2021.11.044. Urology	O Kucuk	05/01/2023
Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy. Clinical nuclear medicine	IO Lawal, C Marcus, DM Schuster, S Goyal, OA Adediran, VR Dhere, SS Joshi, OA Abiodun-Ojo, VA Master, PR Patel, B Fielder, M Goodman, JW Shelton, O Kucuk, B Hershatter, RK Halkar, AB Jani	04/01/2023
Treatment Response to Lycopene in Recurrent Prostate Cancer Confirmed on 18 F-Fluciclovine PET/CT. Clinical nuclear medicine	C Wu, C Marcus, Y Baum, O Kucuk, DM Schuster	04/01/2023
Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus ¹⁸F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	IO Lawal, AB Jani, OA Adediran, S Goyal, OA Abiodun-Ojo, VR Dhere, CV Marcus, SS Joshi, VA Master, PR Patel, M Goodman, JW Shelton, O Kucuk, B Hershatter, B Fielder, RK Halkar, DM Schuster	04/01/2023
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist	TZ Zhuang, D Ravindranathan, Y Liu, DJ Martini, JT Brown, B Nazha, G Russler, LB Yantorni, S Caulfield, BC Carthon, O Kucuk, VA Master, MA Bilen	03/17/2023
Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy. Critical reviews in food science and nutrition	TK Sahin, B Bilir, O Kucuk	01/01/2023
Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [⁶⁸Ga]Ga DOTATATE PET-CT. Cancers	MA Bilen, A Akintayo, Y Liu, O Abiodun-Ojo, O Kucuk, BC Carthon, DM Schuster, EE Parent	12/08/2022
Walk More, Eat Less, Don't Stress. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	O Kucuk	09/02/2022
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience. Journal of immunotherapy and precision oncology	DJ Martini, TA Olsen, S Goyal, Y Liu, ST Evans, EE Hitron, GA Russler, L Yantorni, S Caulfield, JT Brown, JM Goldman, B Nazha, BC Carthon, WB Harris, O Kucuk, VA Master, MA Bilen	08/01/2022
Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood. Journal for immunotherapy of cancer	JW Carlisle, CS Jansen, MA Cardenas, E Sobierajska, AM Reyes, R Greenwald, L Del Balzo, N Prokhnevska, O Kucuk, BC Carthon, PC Mullane, A Osunkoya, D Baumgarten, F Hosseinzadeh, S Wilkinson, R Lake, AG Sowalsky, Y Liu, VA Master, MA Bilen, H Kissick	07/01/2022
High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells. Nature communications	M Boya, T Ozkaya-Ahmadov, BE Swain, CH Chu, N Asmare, O Civelekoglu, R Liu, D Lee, S Tobia, S Biliya, LD McDonald, B Nazha, O Kucuk, MG Sanda, BB Benigno, CS Moreno, MA Bilen, JF McDonald, AF Sarioglu	06/13/2022
Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials. Cancers	TZ Zhuang, K Case, TA Olsen, JT Brown, BC Carthon, O Kucuk, J Goldman, W Harris, MA Bilen, B Nazha	06/10/2022
Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma. The oncologist	B Nazha, TZ Zhuang, HI Dada, LM Drusbosky, JT Brown, D Ravindranathan, BC Carthon, O Kucuk, J Goldman, VA Master, MA Bilen	06/08/2022
Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer. Urologic oncology	A Hadadi, KE Smith, L Wan, JR Brown, G Russler, L Yantorni, S Caulfield, J Lafollette, M Moore, O Kucuk, B Carthon, B Nazha, Y Liu, MA Bilen	06/01/2022
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients. Clinical genitourinary cancer	DJ Martini, ST Evans, Y Liu, JM Shabto, OE Uner, TA Olsen, JT Brown, GA Russler, L Yantorni, S Caulfield, JM Goldman, B Nazha, WB Harris, VA Master, O Kucuk, BC Carthon, MA Bilen	02/01/2022
Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy. Frontiers in endocrinology	TA Olsen, TZ Zhuang, S Caulfield, DJ Martini, JT Brown, BC Carthon, O Kucuk, W Harris, MA Bilen, B Nazha	01/01/2022
Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah's witness: A case report. Frontiers in oncology	TZ Zhuang, L Harik, S Force, A Hadadi, MA Bilen, JT Brown, BC Carthon, J Goldman, O Kucuk, VA Master, B Nazha	01/01/2022
Overcoming prostate cancer drug resistance with a novel organosilicon small molecule. Neoplasia (New York, N.Y.)	R Zhao, X Ma, L Bai, X Li, K Mamouni, Y Yang, H Liu, A Danaher, N Cook, O Kucuk, RS Hodges, L Gera, D Wu	12/01/2021
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors. The oncologist	DJ Martini, JM Shabto, S Goyal, Y Liu, TA Olsen, ST Evans, BL Magod, D Ravindranathan, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, SS Joshi, HT Kissick, KE Ogan, WB Harris, O Kucuk, BC Carthon, VA Master, MA Bilen	12/01/2021
Clinical Outcomes and Racial Disparities in Metastatic Hormone-Sensitive Prostate Cancer in the Era of Novel Treatment Options. The oncologist	KER Smith, JT Brown, L Wan, Y Liu, G Russler, L Yantorni, S Caulfield, J Lafollette, M Moore, O Kucuk, B Carthon, B Nazha, MA Bilen	11/01/2021
Negative enrichment of circulating tumor cells from unmanipulated whole blood with a 3D printed device. Scientific reports	CH Chu, R Liu, T Ozkaya-Ahmadov, BE Swain, M Boya, B El-Rayes, M Akce, MA Bilen, O Kucuk, AF Sarioglu	10/18/2021
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist	DJ Martini, S Goyal, Y Liu, ST Evans, TA Olsen, K Case, BL Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, WB Harris, HT Kissick, VA Master, O Kucuk, BC Carthon, MA Bilen	10/01/2021
EDITORIAL COMMENT. Urology	O Kucuk	10/01/2021
Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database. Clinical genitourinary cancer	KM Xu, Y Liu, TW Gillespie, AO Osunkoya, B Carthon, MA Bilen, CP Filson, K Ogan, PR Patel, JW Shelton, O Kucuk, S Joshi, AB Jani	08/01/2021
Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology	A Kianmehr, I Faraoni, O Kucuk, A Mahrooz	08/01/2021
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC). Journal for immunotherapy of cancer	RK Pachynski, C Morishima, R Szmulewitz, L Harshman, L Appleman, P Monk, RL Bitting, O Kucuk, F Millard, JD Seigne, SP Fling, HT Maecker, C Duault, N Ramchurren, B Hess, L D'Amico, A Lacroix, JC Kaiser, M Morre, A Grégoire, M Cheever, EY Yu, L Fong	08/01/2021
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Journal for immunotherapy of cancer	JT Brown, Y Liu, JM Shabto, D Martini, D Ravindranathan, EE Hitron, GA Russler, S Caulfield, L Yantorni, SS Joshi, H Kissick, K Ogan, B Nazha, BC Carthon, O Kucuk, WB Harris, VA Master, MA Bilen	07/01/2021
¹⁸F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial. Lancet (London, England)	AB Jani, E Schreibmann, S Goyal, R Halkar, B Hershatter, PJ Rossi, JW Shelton, PR Patel, KM Xu, M Goodman, VA Master, SS Joshi, O Kucuk, BC Carthon, MA Bilen, OA Abiodun-Ojo, AA Akintayo, VR Dhere, DM Schuster	05/22/2021
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist	JT Brown, Y Liu, JM Shabto, DJ Martini, D Ravindranathan, EE Hitron, GA Russler, S Caulfield, LB Yantorni, SS Joshi, H Kissick, K Ogan, WB Harris, BC Carthon, O Kucuk, VA Master, MA Bilen	05/01/2021
Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer. Nature communications	B Zhang, Y Li, Q Wu, L Xie, B Barwick, C Fu, X Li, D Wu, S Xia, J Chen, WP Qian, L Yang, AO Osunkoya, L Boise, PM Vertino, Y Zhao, M Li, HR Chen, J Kowalski, O Kucuk, W Zhou, JT Dong	03/17/2021
Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies. Cancer metastasis reviews	K Mittal, J Kaur, M Jaczko, G Wei, MS Toss, EA Rakha, EAM Janssen, H Søiland, O Kucuk, MD Reid, MV Gupta, R Aneja	03/01/2021
Epithelial protein lost in neoplasm (EPLIN) and prostate cancer: lessons learned from the ARCaP model. American journal of clinical and experimental urology	D Wu, AO Osunkoya, O Kucuk	01/01/2021
Exploratory study of ¹⁸F-fluciclovine pet/ct for response assessment to docetaxel in patients with metastatic castration-resistant prostate cancer. American journal of nuclear medicine and molecular imaging	AA Akintayo, MA Bilen, OA Abiodun-Ojo, O Kucuk, B Carthon, Z Chen, AB Jani, EE Parent, DM Schuster	01/01/2021
Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib. Cancer treatment and research communications	DJ Martini, MR Kline, Y Liu, JM Shabto, BC Carthon, GA Russler, L Yantorni, EE Hitron, S Caulfield, JM Goldman, WB Harris, O Kucuk, VA Master, MA Bilen	01/01/2021
Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database. Clinical and translational radiation oncology	JR Janopaul-Naylor, J Zhong, Y Liu, C Zhang, AO Osunkoya, SS Joshi, MA Bilen, B Carthon, O Kucuk, LM Hartsell, J Shelton, AB Jani	01/01/2021
Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors. Frontiers in oncology	DJ Martini, TA Olsen, S Goyal, Y Liu, ST Evans, B Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, B Nazha, HT Kissick, WB Harris, O Kucuk, BC Carthon, VA Master, MA Bilen	01/01/2021
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade. Frontiers in oncology	TA Olsen, DJ Martini, S Goyal, Y Liu, ST Evans, B Magod, JT Brown, L Yantorni, GA Russler, S Caulfield, JM Goldman, WB Harris, O Kucuk, BC Carthon, VA Master, B Nazha, MA Bilen	01/01/2021
Awareness, Use and Outlook of Complementary and Alternative Medicine (CAM) Options in an Underserved, Uninsured Minority Cancer Patient Population. Integrative cancer therapies	S Bari, I Chineke, A Darwin, A Umar, H Jim, J Muzaffar, S Singh, O Kucuk	01/01/2021
Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer. Theranostics	X Li, L Gera, S Zhang, Y Chen, L Lou, LM Wilson, ZR Xie, G Sautto, D Liu, A Danaher, K Mamouni, Y Yang, Y Du, H Fu, O Kucuk, AO Osunkoya, J Zhou, D Wu	01/01/2021
Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (¹⁸F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer. International journal of radiation oncology, biology, physics	A Jani, E Schreibmann, S Goyal, H Raghuveer, B Hershatter, PJ Rossi, JW Shelton, PR Patel, KM Xu, M Goodman, V Master, SS Joshi, O Kucuk, B Carthon, MA Bilen, S Cooper, B Fielder, O Abiodun-Ojo, VR Dhere, DM Schuster	12/01/2020
Kinless hubs are potential target genes in prostate cancer network. Genomics	IR Mangangcha, MZ Malik, O Kucuk, S Ali, RKB Singh	11/01/2020
Novel small-molecule LG1836 inhibits the in vivo growth of castration-resistant prostate cancer. The Prostate	Y Chen, X Li, K Mamouni, Y Yang, A Danaher, J White, H Liu, O Kucuk, L Gera, D Wu	09/01/2020
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. Cancer medicine	JM Shabto, DJ Martini, Y Liu, D Ravindranathan, J Brown, EE Hitron, GA Russler, S Caulfield, H Kissick, M Alemozaffar, K Ogan, WB Harris, VA Master, O Kucuk, BC Carthon, MA Bilen	04/01/2020
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist	DJ Martini, Y Liu, JM Shabto, BC Carthon, EE Hitron, GA Russler, S Caulfield, HT Kissick, WB Harris, O Kucuk, VA Master, MA Bilen	03/01/2020
Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer. Brachytherapy	BW Fischer-Valuck, YJ Rao, RJ Brenneman, PR Patel, CP Filson, AB Jani, Y Liu, S Goyal, K Xu, A Weiss, O Kucuk, C Cimmino, S Szabo, P Rossi, BC Baumann, J Pattaras, B Hershatter, SA Patel	01/01/2020
Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report. Frontiers in oncology	MA Bilen, JF Jiang, CS Jansen, JT Brown, LR Harik, A Sekhar, H Kissick, SK Maithel, O Kucuk, B Carthon, VA Master	01/01/2020
TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization. Theranostics	Y Li, B Zhang, L Xiang, S Xia, O Kucuk, X Deng, LH Boise, JT Dong	01/01/2020
Identification of key regulators in prostate cancer from gene expression datasets of patients. Scientific reports	IR Mangangcha, MZ Malik, Ö Küçük, S Ali, RKB Singh	11/11/2019
Cetuximab and methotrexate in recurrent or metastatic head and neck squamous cell carcinoma-A single institution analysis of 54 patients. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery	A Sukari, M Nagasaka, M Diab, K Al Sibai, B Atassi, JA Elayoubi, S Kim, Ö Küçük	07/01/2019
Small molecule BKM1972 inhibits human prostate cancer growth and overcomes docetaxel resistance in intraosseous models. Cancer letters	Y Chen, L Gera, S Zhang, X Li, Y Yang, K Mamouni, AY Wu, H Liu, O Kucuk, D Wu	04/01/2019
Genistein Prevents Development of Spontaneous Ovarian Cancer and Inhibits Tumor Growth in Hen Model. Cancer prevention research (Philadelphia, Pa.)	K Sahin, E Yenice, B Bilir, C Orhan, M Tuzcu, N Sahin, IH Ozercan, N Kabil, B Ozpolat, O Kucuk	03/01/2019
Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation. American journal of clinical oncology	J Zhong, J Switchenko, NK Jegadeesh, RJ Cassidy, TW Gillespie, V Master, P Nieh, M Alemozaffar, O Kucuk, B Carthon, CP Filson, MA Bilen, AB Jani	01/01/2019
Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy. Integrative cancer therapies	I Sahin, B Bilir, S Ali, K Sahin, O Kucuk	01/01/2019
Tomato Powder Modulates NF-κB, mTOR, and Nrf2 Pathways during Aging in Healthy Rats. Journal of aging research	K Sahin, C Orhan, M Tuzcu, H Tastan, B Bilir, N Sahin, DA Oner, O Kucuk	01/01/2019
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	JJ Coen, P Zhang, PJ Saylor, CT Lee, CL Wu, W Parker, T Lautenschlaeger, AL Zietman, JA Efstathiou, AB Jani, O Kucuk, L Souhami, JP Rodgers, HM Sandler, WU Shipley	01/01/2019
Soy Isoflavone Supplementation Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and Neck Squamous Cell Carcinoma. Nutrition and cancer	LS Rozek, S Virani, EL Bellile, JMG Taylor, MA Sartor, KR Zarins, A Virani, C Cote, FP Worden, MEP Mark, SA McLean, SA Duffy, GH Yoo, NF Saba, DM Shin, O Kucuk, GT Wolf	01/01/2019
Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial. JMIR research protocols	KM Winters-Stone, SA Kenfield, EL Van Blarigan, EL Moe, JW Ramsdill, K Daniel, G Macaire, K Paich, ER Kessler, O Kucuk, TW Gillespie, KS Lyons, TM Beer, JM Broering, PR Carroll, JM Chan	11/15/2018
The addition of chemotherapy in the definitive management of high risk prostate cancer. Urologic oncology	MJ Ferris, Y Liu, J Ao, J Zhong, M Abugideiri, TW Gillespie, BC Carthon, MA Bilen, O Kucuk, AB Jani	11/01/2018
Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer. Molecular cancer therapeutics	Y Yang, K Mamouni, X Li, Y Chen, S Kavuri, Y Du, H Fu, O Kucuk, D Wu	09/01/2018
A Novel Flavonoid Composition Targets Androgen Receptor Signaling and Inhibits Prostate Cancer Growth in Preclinical Models. Neoplasia (New York, N.Y.)	K Mamouni, S Zhang, X Li, Y Chen, Y Yang, J Kim, MG Bartlett, IM Coleman, PS Nelson, O Kucuk, D Wu	08/01/2018
Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab. Clinical genitourinary cancer	MA Bilen, GMA Dutcher, Y Liu, D Ravindranathan, HT Kissick, BC Carthon, O Kucuk, WB Harris, VA Master	06/01/2018
Design, synthesis, and evaluation of the antiproliferative activity of hydantoin-derived antiandrogen-genistein conjugates. Bioorganic & medicinal chemistry	A George, I Raji, B Cinar, O Kucuk, AK Oyelere	05/01/2018
Lycopene Protects Against Spontaneous Ovarian Cancer Formation in Laying Hens. Journal of cancer prevention	K Sahin, E Yenice, M Tuzcu, C Orhan, C Mizrak, IH Ozercan, N Sahin, B Yilmaz, B Bilir, B Ozpolat, O Kucuk	03/01/2018
Chemopreventive and Antitumor Efficacy of Curcumin in a Spontaneously Developing Hen Ovarian Cancer Model. Cancer prevention research (Philadelphia, Pa.)	K Sahin, C Orhan, M Tuzcu, N Sahin, H Tastan, İH Özercan, O Güler, N Kahraman, O Kucuk, B Ozpolat	01/01/2018
Mifepristone Has Limited Activity to Enhance the In Vivo Efficacy of Docetaxel and Enzalutamide Against Bone Metastatic and Castration-Resistant Prostate Cancer. Anticancer research	Y Yang, X Li, K Mamouni, O Kucuk, D Wu	11/01/2017
A Comprehensive Definition for Integrative Oncology. Journal of the National Cancer Institute. Monographs	CM Witt, LG Balneaves, MJ Cardoso, L Cohen, H Greenlee, P Johnstone, Ö Kücük, J Mailman, JJ Mao	11/01/2017
A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma. Asian journal of urology	RR Sekar, D Patil, Y Baum, J Pearl, A Bausum, MA Bilen, O Kucuk, WB Harris, BC Carthon, M Alemozaffar, CP Filson, JG Pattaras, PT Nieh, K Ogan, VA Master	10/01/2017
Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer. International journal of oncology	B Bilir, NV Sharma, J Lee, B Hammarstrom, A Svindland, O Kucuk, CS Moreno	07/01/2017
Soy foods, isoflavones, and breast cancer. Cancer	O Kucuk	06/01/2017
Time-dependent effects of prognostic biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine	WB Harris, C Zhang, Y Liu, DK Robertson, MY Akbashev, BM Lingerfelt, O Kucuk, BC Carthon, TW Gillespie, AO Osunkoya, VA Master	06/01/2017
Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology. Urologic oncology	RS Gerhard, D Patil, Y Liu, K Ogan, M Alemozaffar, AB Jani, ON Kucuk, VA Master, TW Gillespie, CP Filson	05/01/2017
Impact of ¹⁸F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	AB Jani, E Schreibmann, PJ Rossi, J Shelton, K Godette, P Nieh, VA Master, O Kucuk, M Goodman, R Halkar, S Cooper, Z Chen, DM Schuster	03/01/2017
The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer. Cancer	N Jegadeesh, Y Liu, C Zhang, J Zhong, RJ Cassidy, T Gillespie, O Kucuk, P Rossi, VA Master, M Alemozaffar, AB Jani	02/01/2017
Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors. Bone marrow transplantation	Z DeFilipp, CB Rosand, DA Goldstein, VA Master, BC Carthon, WB Harris, O Kucuk, Z Al-Kadhimi, JB Cohen, CR Flowers, MJ Lechowicz, AK Nooka, JL Kaufman, AA Langston, Z Chen, J Arora, EK Waller	01/01/2017
Lycopene in the Prevention of Radiation-Induced Esophagitis. Nutrition and cancer	H Coskun, F Andic, YK Daglıoglu, F Doran, K Sahin, C Tunalı, O Kucuk	01/01/2017
Ginger augmented chemotherapy: A novel multitarget nontoxic approach for cancer management. Molecular nutrition & food research	R Saxena, PC Rida, O Kucuk, R Aneja	06/01/2016
Inhibition of skeletal growth of human prostate cancer by the combination of docetaxel and BKM1644: an aminobisphosphonate derivative. Oncotarget	S Zhang, L Gera, K Mamouni, X Li, Z Chen, O Kucuk, D Wu	05/10/2016
How to be good at being bad: centrosome amplification and mitotic propensity drive intratumoral heterogeneity. Cancer metastasis reviews	PC Rida, G Cantuaria, MD Reid, O Kucuk, R Aneja	12/01/2015
Designing a broad-spectrum integrative approach for cancer prevention and treatment. Seminars in cancer biology	KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, K Aquilano, J Arbiser, A Arreola, A Arzumanyan, SS Ashraf, AS Azmi, F Benencia, D Bhakta, A Bilsland, A Bishayee, SW Blain, PB Block, CS Boosani, TE Carey, A Carnero, M Carotenuto, SC Casey, M Chakrabarti, R Chaturvedi, GZ Chen, H Chen, S Chen, YC Chen, BK Choi, MR Ciriolo, HM Coley, AR Collins, M Connell, S Crawford, CS Curran, C Dabrosin, G Damia, S Dasgupta, RJ DeBerardinis, WK Decker, P Dhawan, AME Diehl, JT Dong, QP Dou, JE Drew, E Elkord, B El-Rayes, MA Feitelson, DW Felsher, LR Ferguson, C Fimognari, GL Firestone, C Frezza, H Fujii, MM Fuster, D Generali, AG Georgakilas, F Gieseler, M Gilbertson, MF Green, B Grue, G Guha, D Halicka, WG Helferich, P Heneberg, P Hentosh, MD Hirschey, LJ Hofseth, RF Holcombe, K Honoki, HY Hsu, GS Huang, LD Jensen, WG Jiang, LW Jones, PA Karpowicz, WN Keith, SP Kerkar, GN Khan, M Khatami, YH Ko, O Kucuk, RJ Kulathinal, NB Kumar, BS Kwon, A Le, MA Lea, HY Lee, T Lichtor, LT Lin, JW Locasale, BL Lokeshwar, VD Longo, CA Lyssiotis, KL MacKenzie, M Malhotra, M Marino, ML Martinez-Chantar, A Matheu, C Maxwell, E McDonnell, AK Meeker, M Mehrmohamadi, K Mehta, GA Michelotti, RM Mohammad, SI Mohammed, DJ Morre, V Muralidhar, I Muqbil, MP Murphy, GP Nagaraju, R Nahta, E Niccolai, S Nowsheen, C Panis, F Pantano, VR Parslow, G Pawelec, PL Pedersen, B Poore, D Poudyal, S Prakash, M Prince, L Raffaghello, JC Rathmell, WK Rathmell, SK Ray, J Reichrath, S Rezazadeh, D Ribatti, L Ricciardiello, RB Robey, F Rodier, HPV Rupasinghe, GL Russo, EP Ryan, AK Samadi, I Sanchez-Garcia, AJ Sanders, D Santini, M Sarkar, T Sasada, NK Saxena, RE Shackelford, HMC Shantha Kumara, D Sharma, DM Shin, D Sidransky, MD Siegelin, E Signori, N Singh, S Sivanand, D Sliva, C Smythe, C Spagnuolo, DM Stafforini, J Stagg, PR Subbarayan, T Sundin, WH Talib, SK Thompson, PT Tran, H Ungefroren, MG Vander Heiden, V Venkateswaran, DS Vinay, PJ Vlachostergios, Z Wang, KE Wellen, RL Whelan, ES Yang, H Yang, X Yang, P Yaswen, C Yedjou, X Yin, J Zhu, M Zollo	12/01/2015
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. Seminars in cancer biology	ARMR Amin, PA Karpowicz, TE Carey, J Arbiser, R Nahta, ZG Chen, JT Dong, O Kucuk, GN Khan, GS Huang, S Mi, HY Lee, J Reichrath, K Honoki, AG Georgakilas, A Amedei, A Amin, B Helferich, CS Boosani, MR Ciriolo, S Chen, SI Mohammed, AS Azmi, WN Keith, D Bhakta, D Halicka, E Niccolai, H Fujii, K Aquilano, SS Ashraf, S Nowsheen, X Yang, A Bilsland, DM Shin	12/01/2015
Cancer biomarkers. Molecular aspects of medicine	O Kucuk	11/01/2015
C-reactive protein in urologic cancers. Molecular aspects of medicine	J Huang, Y Baum, M Alemozaffar, K Ogan, W Harris, O Kucuk, VA Master	11/01/2015
Docetaxel-induced polyploidization may underlie chemoresistance and disease relapse. Cancer letters	A Ogden, PC Rida, BS Knudsen, O Kucuk, R Aneja	10/28/2015
Carotenoids and non-alcoholic fatty liver disease. Hepatobiliary surgery and nutrition	B Yilmaz, K Sahin, H Bilen, IH Bahcecioglu, B Bilir, S Ashraf, KJ Halazun, O Kucuk	06/01/2015
Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases. The Canadian journal of urology	N Fatima, DJ Canter, BC Carthon, O Kucuk, VA Master, PT Nieh, K Ogan, AO Osunkoya	06/01/2015
Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model. Archives of biochemistry and biophysics	K Sahin, B Cross, N Sahin, K Ciccone, S Suleiman, AO Osunkoya, V Master, W Harris, B Carthon, R Mohammad, B Bilir, K Wertz, CS Moreno, CL Walker, O Kucuk	04/15/2015
Die-hard survivors: heterogeneity in apoptotic thresholds may underlie chemoresistance. Expert review of anticancer therapy	A Ogden, PC Rida, MD Reid, O Kucuk, R Aneja	03/01/2015
Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck. Avicenna journal of medicine	A Sukari, M Al-Hajeili, M Salem, L Heilbrun, D Smith, G Yoo, JR Jacobs, HS Lin, O Kucuk	01/01/2015
Eugenol-rich Fraction of Syzygium aromaticum (Clove) Reverses Biochemical and Histopathological Changes in Liver Cirrhosis and Inhibits Hepatic Cell Proliferation. Journal of cancer prevention	S Ali, R Prasad, A Mahmood, I Routray, TS Shinkafi, K Sahin, O Kucuk	12/01/2014
Genistein protects hematopoietic stem cells against G-CSF-induced DNA damage. Cancer prevention research (Philadelphia, Pa.)	LR Souza, E Silva, E Calloway, O Kucuk, M Rossi, ML McLemore	05/01/2014
Enhancement of Cisplatin sensitivity in human cervical cancer: epigallocatechin-3-gallate. Frontiers in nutrition	U Kilic, K Sahin, M Tuzcu, N Basak, C Orhan, B Elibol-Can, E Kilic, F Sahin, O Kucuk	01/01/2014
External validation of the modified Glasgow prognostic score for renal cancer. Indian journal of urology : IJU : journal of the Urological Society of India	CG Tai, TV Johnson, A Abbasi, L Herrell, WB Harris, O Kucuk, DJ Canter, K Ogan, JG Pattaras, PT Nieh, VA Master	01/01/2014
Pomegranate extract inhibits the bone metastatic growth of human prostate cancer cells and enhances the in vivo efficacy of docetaxel chemotherapy. The Prostate	Y Wang, S Zhang, S Iqbal, Z Chen, X Wang, YA Wang, D Liu, K Bai, C Ritenour, O Kucuk, D Wu	12/23/2013
Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. Journal of translational medicine	B Bilir, O Kucuk, CS Moreno	11/04/2013
Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells. The Prostate	S Zhang, Y Wang, Z Chen, S Kim, S Iqbal, A Chi, C Ritenour, YA Wang, O Kucuk, D Wu	11/01/2013
Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition. The Journal of biological chemistry	S Zhang, X Wang, S Iqbal, Y Wang, AO Osunkoya, Z Chen, Z Chen, DM Shin, H Yuan, YA Wang, HE Zhau, LW Chung, C Ritenour, O Kucuk, D Wu	01/18/2013
The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy. The British journal of nutrition	B Lazarevic, C Hammarström, J Yang, H Ramberg, LM Diep, SJ Karlsen, O Kucuk, F Saatcioglu, KA Taskèn, A Svindland	12/28/2012
Lycopene counteracts the hepatic response to 7,12-dimethylbenz[a]anthracene by altering the expression of Bax, Bcl-2, caspases, and oxidative stress biomarkers. Pharmaceutical biology	CA Agca, M Tuzcu, H Gencoglu, F Akdemir, S Ali, K Sahin, O Kucuk	12/01/2012
Tomato powder impedes the development of azoxymethane-induced colorectal cancer in rats through suppression of COX-2 expression via NF-κB and regulating Nrf2/HO-1 pathway. Molecular nutrition & food research	M Tuzcu, A Aslan, Z Tuzcu, M Yabas, IH Bahcecioglu, IH Ozercan, O Kucuk, K Sahin	09/01/2012
Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association	R Ulu, A Dogukan, M Tuzcu, H Gencoglu, M Ulas, N Ilhan, I Muqbil, RM Mohammad, O Kucuk, K Sahin	05/01/2012
Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells. BMC cancer	CJ Phillip, CK Giardina, B Bilir, DJ Cutler, YH Lai, O Kucuk, CS Moreno	04/11/2012
Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy. International journal of surgical oncology	BW Cross, TV Johnson, AB Derosa, K Ogan, JG Pattaras, PT Nieh, O Kucuk, WB Harris, VA Master	01/01/2012
Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. ISRN oncology	Z Kafri, LK Heilbrun, A Sukari, G Yoo, J Jacobs, HS Lin, H Mulrenan, D Smith, O Kucuk	01/01/2012
Dietary agents in cancer chemoprevention and treatment. Journal of oncology	JJ Raffoul, O Kucuk, FH Sarkar, GG Hillman	01/01/2012
PDGF upregulates Mcl-1 through activation of β-catenin and HIF-1α-dependent signaling in human prostate cancer cells. PloS one	S Iqbal, S Zhang, A Driss, ZR Liu, HR Kim, Y Wang, C Ritenour, HE Zhau, O Kucuk, LW Chung, D Wu	01/01/2012
EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis. Oncogene	S Zhang, X Wang, AO Osunkoya, S Iqbal, Y Wang, Z Chen, S Müller, Z Chen, S Josson, IM Coleman, PS Nelson, YA Wang, R Wang, DM Shin, FF Marshall, O Kucuk, LW Chung, HE Zhau, D Wu	12/15/2011
Inhibitory effects of combination of lycopene and genistein on 7,12- dimethyl benz(a)anthracene-induced breast cancer in rats. Nutrition and cancer	K Sahin, M Tuzcu, N Sahin, F Akdemir, I Ozercan, S Bayraktar, O Kucuk	11/01/2011
Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma. The Journal of urology	TV Johnson, S Ali, A Abbasi, O Kucuk, WB Harris, K Ogan, J Pattaras, PT Nieh, FF Marshall, AO Osunkoya, VA Master	10/01/2011
Clinical trials of antioxidants as cancer prevention agents: past, present, and future. Free radical biology & medicine	M Goodman, RM Bostick, O Kucuk, DP Jones	09/01/2011
A tomato lycopene complex protects the kidney from cisplatin-induced injury via affecting oxidative stress as well as Bax, Bcl-2, and HSPs expression. Nutrition and cancer	A Dogukan, M Tuzcu, CA Agca, H Gencoglu, N Sahin, M Onderci, IH Ozercan, N Ilhan, O Kucuk, K Sahin	01/01/2011
Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial. Nutrition and cancer	B Lazarevic, G Boezelijn, LM Diep, K Kvernrod, O Ogren, H Ramberg, A Moen, N Wessel, RE Berg, W Egge-Jacobsen, C Hammarstrom, A Svindland, O Kucuk, F Saatcioglu, KA Taskèn, SJ Karlsen	01/01/2011
Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma. Urology	TV Johnson, A Abbasi, A Owen-Smith, AN Young, O Kucuk, WB Harris, AO Osunkoya, K Ogan, J Pattaras, PT Nieh, FF Marshall, VA Master	09/01/2010
Cancer prevention with natural compounds. Seminars in oncology	NP Gullett, AR Ruhul Amin, S Bayraktar, JM Pezzuto, DM Shin, FR Khuri, BB Aggarwal, YJ Surh, O Kucuk	06/01/2010
Second international congress on nutrition and cancer. Nutrition and cancer	O Kucuk	01/01/2010
Perspectives for cancer prevention with natural compounds. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	AR Amin, O Kucuk, FR Khuri, DM Shin	06/01/2009
Cancer-induced cachexia: a guide for the oncologist. Journal of the Society for Integrative Oncology	N Gullett, P Rossi, O Kucuk, PA Johnstone	01/01/2009
First International Congress on Nutrition and Cancer. Nutrition and cancer	O Kucuk	01/01/2009

Awards

Atlanta Magazine "Top Doctors," 2015-2019
Scientific and Technological Research Council of Turkey (TÜBİTAK) Science Award, 2018
Cancer Researcher of the Year Award, Gateway for Cancer Research, 2016
College Teaching Award, Wayne State University
President's Achievement Award for Community Research, Karmanos Cancer Institute
President's Achievement Award for Outstanding Service, Karmanos Cancer Institute
Faculty Research Excellence Award, School of Medicine, Wayne State University
Inaugural Director, Center for Integrative Health and Medicine, Emory University

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.9	One star One star One star One star One half star	Provider showed concern
4.9	One star One star One star One star One half star	Provider explained things clearly
4.9	One star One star One star One star One half star	Provider discussed treatment options
4.9	One star One star One star One star One half star	Provider included you in decisions
4.9	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	04/16/2025	Professional caring pleasant knowledgeable MD
One star One star One star One star One star	03/22/2025	My care provider was outstanding. I'm very grateful.!!!
One star One star One star One star One star	03/19/2025	I have and will continue to recommend Emory.
One star One star One star One star One star	03/19/2025	I have recommended Dr Cucuk to many I have talked to concerning my cancer treatment at Emory Winship Cancer Center.
One star One star One star One star One star	03/13/2025	Good job
One star One star One star One star One star	03/12/2025	DR K is the best !!
One star One star One star One star One star	02/27/2025	I hope the Emory Pain Center Dr. Cuchuck recommended can help me.
One star One star One star One star One star	02/23/2025	Dr Kuchk has always been upfront and direct but with a good bedside manner. He lets you know what is working and what is not. I wouldn't have it any other way.
One star One star One star One star One star	02/23/2025	Good. Discuss my medicine and health issues
One star One star One star One star One star	02/19/2025	Extremely competent in relaying additional options for my condition and very encouraging.
One star One star One star One star One star	02/13/2025	Communication was clear & concise.
One star One star One star One star One star	02/07/2025	Excellent
One star One star One star One star One star	02/05/2025	We always have the best results and communication with our Doctor Omer Kucuk.
One star One star One star One star One star	12/28/2024	I am extremely satisfied, thank you.
One star One star One star One star One star	12/18/2024	All excellent
One star One star One star One star One star	12/18/2024	The Emory WinshipTeam has always exceeded my expectations
One star One star One star One star One star	12/04/2024	Good
One star One star One star One star One star	12/04/2024	Dr K is incredibly knowledgeable and friendly
One star One star One star One star One star	11/20/2024	Discussed my treatment and offer suggestions that I went along with.
One star One star One star One star One star	11/20/2024	This is my second bout with with c' and had l known this doctor in 2012, l would not be in clinic today.He is attentive, informative, ease to talk with, and above all Excellent communication skills.Met many doctors in life, he is now neck and neck with my primary care physician
One star One star One star One star One star	11/20/2024	Emory and Team Kucuk set the standard for health care.
One star One star One star One star One star	11/13/2024	Doctor is courteous & patient. He answered my questions with detail. He knew my situation and offered recommendations. He outlined a plan for the future.
One star One star One star One star One star	11/07/2024	All good
One star One star One star One star One star	10/26/2024	All above were involved and services provided was excellent
One star One star One star One star One star	10/25/2024	Good
One star One star One star One star One star	10/23/2024	We always get excellent service.
One star One star One star One star One star	10/23/2024	I consider myself exceptionally blessed to be under the care of Dr. Kucuk. He listens to concerns I have regarding treatment options and plans treatment accordingly.
One star One star One star One star One star	10/17/2024	Most excellent care provider. They don't make anyone like him any more!
One star One star One star One star One star	10/16/2024	Dr Kucuk excellent
One star One star One star One star One star	08/22/2024	Prof. Omar Kucuk was knowledgeable, compassionate, and provided me with the medical care I urgently needed.
One star One star One star One star One star	08/21/2024	Thank you Dr. Kuchuk!
One star One star One star One star One star	08/21/2024	Dr. Kucuk is "simply the best!
One star One star One star One star One star	08/01/2024	I would rate the overall care provided by Dr Kucuk and his team as excellent and I would not hesitate to recommend their services to others.
One star One star One star One star One star	08/01/2024	Excellent!
One star One star One star One star One star	07/11/2024	Dr.. Kucuk keeps me well informed.
One star One star One star One star One star	07/03/2024	I have already recommended to others.
One star One star One star One star One star	06/20/2024	Good experience
One star One star One star One star One star	06/19/2024	Dr Kucuk is the highest level Professional I have been to. His skills go far beyond the qualified Doctor in that he clearly cares about the patient's best outcome. And he is always friendly and smiling. He's the best.
One star One star One star One star One star	06/07/2024	Good
One star One star One star One star One star	06/06/2024	Good
One star One star One star One star One star	06/06/2024	Dr Kucuk thoroughly went over my labs and discussed with me the course of action for the following months
One star Empty star Empty star Empty star Empty star	06/01/2024	The doctor did not review current bloodwork. He only reviewed an Apirll bloodwork from my hospital visit. I got a copy of bloodwork after the visit and there were significant changes in the updated copy compared to the hospital report. He said he would call after he received. There has not been a call since the visit on 5//28/24. I sent a portal message to please call. No response yet
One star One star One star One star One star	05/22/2024	An excellent nurse! Very professional and knowledgeable!!!
One star One star One star One star One star	05/15/2024	Dr Kucuk is the best. Smart to the point